semaglutide nasal spray Compounded Oxytocin try Simply Saline Allergy Sinus Mist. Chinese biotech aims to finish

& Kotsa, K

Estimated treatment differences between cohorts showed the semaglutide 2.4 mg cohort had significantly greater percentage ( 15.0%) and absolute reduction in weight ( 15.7 kg), greater reduction in BMI ( 4.2 kg/m 2 ), and significantly greater improvements in cardiometabolic risk factors, including SBP ( 6.7 mmHg), DBP ( 2.7 mmHg), HbA1c ( 0.5%), HDL-C (1.2 mg/dl), LDL-C ( 10.4 mg/dl), and triglycerides ( 34.3 mg/dl) at 12 months

Buyer takeaway: Gala GLP-1 is a direct-access telehealth platform serving adults in all 50 states

GLP-1 Prescribing Is Rising But Not Equally Across Populations November 11, 2025 Summary: Prescriptions for GLP-1 medications have increased sharply for obesity, type 2 diabetes, and people with both conditions